Rentabilitas dodolan miturut bathi resik 23andMe Holding Co (ME)

23andMe Holding Co - logo grafis emiten ME

The transition to a paid subscription model and AI-driven health analysis is yielding a moderate effect while therapeutic developments are still taking shape for 23andMe Holding Co. (ME). Geopolitical tensions are complicating patent protection and component logistics. The company's net margin profile confirms these risks, with the indicator standing at -187.00. However, diversification through the integration of genetic testing with drug discovery based on a massive array of DNA data creates a unique foundation for resilience.

23andMe Holding Co. (ME) - Tingkat bathi resik saka 04.07.2022 nganti 05.04.2025

Rincian metrik keuangan lan pasar 23andMe Inc. (ME)

- rega saham lan prakiraan rega para ahli:
Ringkesan analisis perusahaan:23andMe Holding Co - ME
Produk asil prodhuksi 23andMe Holding Co

Amid cost restructuring and the privatization of 23andMe Holding Co. (ME), the net profit margin chart becomes a key tool for monitoring efficiency. This indicator determines the share of net income relative to total revenue. The calculation is based on a daily comparison of the bottom line against total income. Positive momentum confirms the success of Anne Wojcicki's strategy; however, investors should consider the debt load, which could offset operational growth.

Pesaing 23andMe Holding Co. (ME)

A (Agilent Technologies) - Rentabilitas dodolan miturut bathi resik|DGX: Rentabilitas resik perusahaan|Margin resik Illumina Platform|EXAS (Exact Sciences) - Rentabilitas resik perusahaan|Rentabilitas dodolan miturut bathi resik RVTY (PerkinElmer)|Bio-Rad - Rentabilitas dodolan resik|Margin dodolan resik NNNN (Anbio)|Tingkat bathi resik SHC|QDEL - Margin resik|OPK: Margin resik|caredx.com (CDNA) - Margin resik|MRVI (Maravai LifeSciences) - Margin resik|FLGT (Fulgent) - Margin dodolan resik|Standard BioTools Inc (LAB) - Margin dodolan perusahaan|Margin dodolan resik CTKB|Rentabilitas dodolan miturut bathi resik OraSure Technologies Inc OSUR|Margin dodolan resik XGN (Exagen Diagnostics)|Margin dodolan resik mdxhealth.com MDXH|LUCD - Margin resik|PRE: Margin resik|IMDX (Insight Molecular Diagnostics Inc) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan miturut bathi resik Trinity Biotech PLC|PRPH (prophaselabs.com) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik Ainos, Inc. (AIMD)|Margin dodolan resik CODX|HSCS (HeartSciences) - Tingkat bathi resik|Margin resik Biomerica, Inc BMRA|CDIO - Rentabilitas dodolan miturut bathi resik|ONCO - Margin resik|VRAX - Margin dodolan resik|Bluejay Diagnostics Inc (BJDX) - Margin resik|Aspira Women's Health Inc. - Tingkat bathi resik|AXDX (Accelerate Diagnostics Inc) - Margin dodolan resik|Margin resik Centogene N.V. CNTG|Margin dodolan resik ENZ|Margin resik FRES (Fresh2)|Margin dodolan resik GENE (Genetic Technologies Limited)|Psychemedics Corp. (PMD) - Margin resik